EMA Application withdrawn: Neffy (epinephrine) — Ars Pharmaceuticals Irl Limited

View source ↗

Summary

The EMA withdrew the application for Neffy (epinephrine) by Ars Pharmaceuticals Irl Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis
• Hypersensitivity

Drugs mentioned

• NEFFY (epinephrine)

Snippet

Status: Application withdrawn. Therapeutic area: Hypersensitivity;Anaphylaxis. MAH: Ars Pharmaceuticals Irl Limited